Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.34 | 13.98 |
| PEG Ratio (TTM) | -0.91 | -2.50 |
| P/S Ratio (TTM) | 1.11 | 2.55 |
| P/B Ratio (TTM) | 0.65 | 1.81 |
| P/FCF Ratio (TTM) | N/A | 26.34 |
| Price to 5YR AVG Earnings Ratio | N/A | 16.92 |
| Price to 5YR AVG FCF Ratio | N/A | 32.64 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.35% | 5.69% |
| ROE (TTM) | 5.77% | 13.92% |
| Net Profit Margin (TTM) | 9.71% | 19.16% |
| ROIC 5YR AVG | N/A | 3.15% |
Growth (28%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 0.41% | 46.98% | N/A |
| Revenue | 0.01% | -4.20% | N/A |
| Net Income | 44.03% | 46.20% | N/A |
| Cash Flow | -25.00% | -79.82% | N/A |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.07 | 6.74 |
| Quick Ratio (TTM) | 3.65 | 7.07 |
| D/E Ratio (TTM) | 0.01 | 0.26 |
| Interest Coverage (TTM) | N/A | 9.66 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 0.99 | 2.57 |
| LTL to 5YR AVG FCF | N/A | 4.20 |
| Shares Outstanding Growth 5YR AVG | N/A | -2.28% |